Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 19, 2018

DrugPatentWatch Database Preview

Ammonium chloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ammonium chloride and what is the scope of ammonium chloride patent protection?
Ammonium chloride is the generic ingredient in four branded drugs marketed by Abbott, Gd Searle Llc, Mcgaw, B Braun, and Hospira, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for ammonium chloride.

Summary for ammonium chloride

US Patents:	0
Tradenames:	4
Applicants:	5
NDAs:	5
Drug Master File Entries:	38
Bulk Api Vendors:	53
Clinical Trials:	3
Formulation / Manufacturing:	see details
DailyMed Link:	ammonium chloride at DailyMed

US Patents and Regulatory Information for ammonium chloride

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	AMMONIUM CHLORIDE 2.14%	ammonium chloride	INJECTABLE;INJECTION	085734-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Gd Searle Llc	AMMONIUM CHLORIDE	ammonium chloride	INJECTABLE;INJECTION	086205-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Mcgaw	AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE	ammonium chloride	INJECTABLE;INJECTION	006580-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Hospira	AMMONIUM CHLORIDE IN PLASTIC CONTAINER	ammonium chloride	INJECTABLE;INJECTION	088366-001	Jun 13, 1984		RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte

QuintilesIMS

Covington

UBS

Mallinckrodt

Baxter

Federal Trade Commission

Queensland Health

Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.